[Transrectal sonographic (TRUS) prostatic volumetry in assessing tumor response to radiation].
The aim of this study was to document the grading-related response of carcinoma of the prostate to radiotherapy, especially in views of the fact that the PSA values of hormonal therapy are not evaluable if hormonal therapy is done prior to radiotherapy or in patients with high likelihood of metastatic spread. Controls were done on 55 patients before, during and after primary external radiotherapy of carcinoma of the prostate with volumetric analysis of transrectal ultrasound (TRUS) of the prostate. There were significant differences between G1 and G2 tumors on the one hand and G3 tumors on the other hand. The latter had a much larger volume to start with and their volume reduced more rapidly after therapy.
Schratter-Sehn
A U
AU
Universitätsklinik für Strahlentherapie und Strahlenbiologie Wien.
Handl-Zeller
L
L
Eilenberger
M
M
Havelec
L
L
Schratter
M
M
D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D005069:Evaluation Studies as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009929:Organ Size; D011467:Prostate / Q000000981:diagnostic imaging* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy; D012007:Rectum; D014463:Ultrasonography
Transrektal sonographische (TRUS-) Prostatavolumetrie zur Beurteilung des Tumoransprechens auf Radiatio.